Corticotropin Side Effects: A Complete Safety Overview

How Corticotropin Works—and Why Side Effects Matter

Corticotropin (also called adrenocorticotropic hormone, or ACTH) is a 39-amino-acid peptide that tells your adrenal glands to produce and release cortisol. This is a natural process—your pituitary gland does this every day. But when you receive corticotropin as a medication, the dose and timing are exogenous (external), which means your body's feedback loops get disrupted. That's why side effects are common: research indicates that sustained elevation of cortisol, even at therapeutic doses, triggers a cascade of metabolic and physiological changes.

Corticotropin has 185 clinical trials registered globally, many dating back decades. The FDA approved it in 1952 for infantile spasms (West syndrome), and it remains a first-line option for that indication. But that long history also means we have extensive real-world safety data.

The Most Common Side Effects

Metabolic and Weight-Related Effects

One of the most frequent complaints from corticotropin users is rapid weight gain and metabolic dysfunction. Clinical data shows that corticotropin-induced weight gain stems from increased appetite, reduced energy expenditure, and preferential fat storage—particularly in the face and upper back (sometimes called "moon face" and "buffalo hump"). Patients on prolonged corticotropin therapy often see 10–20 lbs of weight gain over weeks to months.

Corticotropin also raises blood glucose and can trigger or worsen diabetes. In one systematic review of infantile spasms treatment, hyperglycemia was documented in roughly 15–20% of patients receiving corticotropin, even in children with no prior glucose intolerance.

Mood and Behavioral Changes

Psychiatric side effects are real and sometimes severe. Excess cortisol can cause:

• Insomnia and sleep disruption – cortisol naturally suppresses at night; exogenous corticotropin flattens that rhythm
• Mood elevation or euphoria – not pleasant for everyone; can shift to irritability or anxiety
• Depression – paradoxically, some patients develop depressive symptoms even as cortisol peaks
• Anxiety and restlessness

Research from pediatric trials notes behavioral changes in 20–40% of children on corticotropin, ranging from mild hyperactivity to significant mood swings. In adults, these effects are equally common and sometimes more distressing because patients can articulate them clearly.

Immune Suppression and Infection Risk

Because cortisol is immunosuppressive, corticotropin increases your infection risk. Common problems include:

• Upper respiratory infections (colds, sinusitis)
• Skin and soft tissue infections (impetigo, fungal infections)
• Opportunistic infections (tuberculosis reactivation is a known risk with prolonged corticotropin use)
• Urinary tract infections

If you have latent tuberculosis or are exposed to chickenpox or measles while on corticotropin, your risk of severe disease rises sharply. This is why screening and vaccination status matter before starting treatment.

Fluid Retention and Hypertension

Corticotropin stimulates cortisol, which has mild mineralocorticoid activity (it acts slightly like aldosterone). This can cause:

• Sodium and fluid retention
• Elevated blood pressure
• Swelling in legs and ankles (edema)

Patients with pre-existing hypertension may need dose adjustment or increased antihypertensive medication while on corticotropin.

Serious and Less Common Side Effects

Osteoporosis and Bone Loss

Prolonged corticotropin use accelerates bone loss. Excess cortisol inhibits bone formation and increases bone resorption. Patients on long-term therapy (more than a few months) face increased fracture risk, especially in the spine and hips. This is particularly concerning in children, whose bones are still developing, and in postmenopausal women. Consider Abaloparatide, an anabolic peptide sometimes used alongside corticotropin therapy to help preserve bone density in high-risk patients.

Adrenal Suppression and Withdrawal

When you give the body exogenous corticotropin for weeks or months, your own pituitary-adrenal axis downregulates. If corticotropin is stopped abruptly, your body may not produce enough cortisol on its own, causing:

• Fatigue and weakness
• Low blood pressure
• Hypoglycemia
• Nausea and malaise

This is why corticotropin must be tapered slowly, not stopped cold turkey. Rebound adrenal insufficiency can be dangerous.

Gastrointestinal Issues

Many patients report nausea, vomiting, loss of appetite (despite cortisol's typical appetite-stimulating effect), and abdominal discomfort. Ulcer risk also rises because cortisol increases gastric acid and reduces mucus protection.

Electrolyte Abnormalities

Corticotropin can cause hypokalemia (low potassium) and hypocalcemia (low calcium) due to cortisol's effects on mineral handling. This can lead to muscle weakness, cardiac arrhythmias, and tetany if severe.

Who Is at Higher Risk?

Certain groups face greater side effect burdens:

• Children – rapidly growing bodies are more vulnerable to bone loss, growth stunting, and behavioral changes
• Elderly patients – higher baseline infection risk, frailty, and pre-existing hypertension
• Diabetics – corticotropin will worsen glucose control
• Those with TB history – risk of reactivation
• Patients on prolonged therapy – side effects accumulate over time

Patients using other immunosuppressive drugs (like Bimagrumab, a monoclonal antibody in development for muscle wasting) alongside corticotropin face compounded infection risk and require extra vigilance.

Monitoring and Risk Mitigation

If your clinician prescribes corticotropin, expect regular monitoring:

• Blood pressure checks – at every visit
• Fasting glucose and periodic HbA1c – to catch hyperglycemia early
• Bone density scans (DEXA) – especially for prolonged use
• Electrolyte panels – watching for potassium and calcium drift
• TB testing – before starting, and periodically during treatment
• Infection screening – ask about varicella and measles immunity

Some clinicians co-prescribe potassium supplements, bone-protective agents (bisphosphonates), or gastric protection (proton pump inhibitors) to offset predictable harms.

Comparing Corticotropin to Other Peptide Therapies

Not all peptides carry the same risk burden. For example, ARA-290 is being investigated for neuropathic pain and operates through a completely different mechanism (erythropoietin receptor signaling), with a far narrower adverse effect profile. Similarly, Alexamorelin, a growth hormone secretagogue in research, works on hunger and GI motility rather than cortisol, so metabolic side effects differ substantially.

Corticotropin's side effects are intrinsic to its mechanism: you cannot get the therapeutic benefit (cortisol elevation) without also triggering the off-target effects. This is why corticotropin is reserved for specific, serious indications like infantile spasms or acute exacerbations of certain autoimmune conditions—not for everyday use.

The Bottom Line on Corticotropin Safety

Corticotropin is FDA-approved and, when used under close medical supervision for appropriate indications, the benefits often outweigh the risks. More than 185 clinical trials have documented its efficacy and safety profile over decades. But it is not a benign treatment. Side effects are common, sometimes bothersome, and occasionally serious. The key is informed use: understand the risks, get baseline testing, monitor closely, and use the lowest effective dose for the shortest duration possible.

If you're considering corticotropin or currently using it, open dialogue with your prescriber about which side effects concern you most and what mitigation strategies are available.